Mapping disparities in access to lecanemab in Georgia
Authors:
Open Access
- 17 April 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (4) , e70100
Abstract
INTRODUCTION: The approval of lecanemab‐irmb offers potential disease‐modifying treatments for Alzheimer's disease (AD), but geographical access barriers to infusion and amyloid positron emission tomography (PET) imaging sites might prevent timely access to the drug. We examined disparities in access to lecanemab infusion sites and amyloid PET scan facilities in Georgia's 159 counties.METHODS: Facility location maps were used to examine lecanemab access. We used drive time analysis to identify and map counties by drive time.RESULTS: No rural county had an amyloid PET scan center and only one had a lecanemab infusion center. Residents in rural counties need to drive > 1 hour on average to reach the nearest facility, which is statistically significantly longer than those in non‐rural counties.DISCUSSION: Lack of access and long drive times pose health equity issues for those in rural counties, which already have a higher percentage of older residents and a higher prevalence of behavioral AD risk factors.Highlights: We mapped amyloid positron emission tomography (PET) scan and lecanemab infusion facilities in Georgia. We examined the drive time to the nearest facility in each county. One lecanemab infusion facility and no amyloid PET scan facilities were found in rural counties. The mean drive time to the nearest facility is significantly longer for rural counties. The results call for policies and resources to address this health disparity issue.Keywords
This publication has 22 references indexed in Scilit:
- The Georgia Memory Net: Implementation of a statewide program to diagnose and treat Alzheimer's disease and related dementiasJournal of the American Geriatrics Society, 2022
- Access to primary care and cognitive impairment: results from a national community study of aging AmericansBMC Geriatrics, 2021
- A Shortage of Neurologists – We Must Act NowNeurology, 2021
- Global maps of travel time to healthcare facilitiesNature Medicine, 2020
- Temporal and Geographic Variation in the Incidence of Alzheimer's Disease Diagnosis in the US between 2007 and 2014Journal of the American Geriatrics Society, 2019
- Drive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US StatesJAMA, 2019
- Fear and Uncertainty Do Not Influence Reported Willingness to Undergo Lumbar Punctures in a U.S. Multi-Cultural CohortFrontiers in Aging Neuroscience, 2017
- Routine lumbar puncture for the early diagnosis of Alzheimer's disease. Is it safe?Frontiers in Aging Neuroscience, 2014
- Supply and demand analysis of the current and future US neurology workforceNeurology, 2013
- The Concept of AccessMedical Care, 1981